🇺🇸 FDA
Patent

US 9044509

Inhibition of HIV infection through chemoprophylaxis

granted A61KA61K31/513A61K31/675

Quick answer

US patent 9044509 (Inhibition of HIV infection through chemoprophylaxis) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/513, A61K31/675, A61K31/683, A61K31/7072